Quick Answer
Niagen Bioscience, Inc. reported Long-Term Debt of $0.00 for fiscal year 2016.
Niagen Bioscience, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2016 | $0.00 | -100.0% |
| 2015 | $3.35M | +69.2% |
| 2014 | $1.98M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2016 | $0.00 | -100.0% | -100.0% |
| March 31, 2016 | $2.91M | +62.4% | -12.9% |
| December 31, 2015 | $3.35M | +69.2% | -20.8% |
| September 30, 2015 | $4.23M | — | -8.7% |
| June 30, 2015 | $4.63M | — | +157.9% |
| March 31, 2015 | $1.79M | — | -9.2% |
| December 31, 2014 | $1.98M | — | — |
- Niagen Bioscience, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Over the 2014–2016 period, Niagen Bioscience, Inc.’s long-term debt has declined by 100.0% (from $1.98 million to $0.00).
- The most recent figure is from Niagen Bioscience, Inc.’s fiscal year 2016 report (Form 10-K), filed with the SEC on March 16, 2017.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: